Anzeige
++++++ Breaking News: Was bahnt sich bei diesem Kupfer-Explorer an? +++ Was bahnt sich bei diesem Kupfer-Explorer an? ++++++
PortfolioPlus
Dein Depot in Echtzeit – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
News, Infos & good to know Forum: Community User: Lirumlarum1
Kommentare 136
Lirumlarum1,
27.08.2020 18:51 Uhr
0
Harry Reid and Alex Trebek tried Patrick Soon-Shiong’s experimental cancer therapy. Can their results be duplicated in a clinical trial?
https://www.statnews.com/2020/07/29/harry-reid-alex-trebek-cancer-patrick-soon-shiong/
Lirumlarum1,
27.08.2020 17:05 Uhr
0
Patrick Soon Shiong auf dem heutigen Forbes Cover:
https://www.forbes.com/sites/alexknapp/2020/08/27/the-inside-story-of-biotechs-barnum-and-his-covid-cures/#18a237d4208a
Lirumlarum1,
24.08.2020 17:22 Uhr
0
NantKwest and ImmunityBio Sign Collaboration Agreement for Joint Development, Manufacturing, Marketing, and Commercialization of COVID-19 Vaccine and Related Therapeutics
https://nantkwest.com/category/press-releases/
Lirumlarum1,
22.08.2020 15:51 Uhr
0
This was posted by a young stage 3 pancreatic cancer survivor , now NED (No Evidence of Disease). She referenced the Bloomberg Patrick Soon-Shiong (PSS)interview at JP Morgan Health Care Conference 9 month ago, this young lady posted pictures of her birthday celebration: “great news for pancreatic cancer patient and other cancer patients, watch how Dr. PSS from Chan Soon Shiong Foundation (they specialize on pancreatic cancer which I am now NED. Dr PSS talks about how he has completely eradicated Pancreatic Tumors in his patient. He also talks about how he does the same for lung, breast , skin and liver cancer patient with 100% complete eradication of the tumor.
https://youtu.be/VMaCZLVGfGM
Lirumlarum1,
22.08.2020 15:50 Uhr
0
Cord Blood Registry (CBR®) by Generate Life Sciences Partners with NantKwest to Develop Covid-19 Treatment
Aug 10, 2020 | Press Releases
https://nantkwest.com/cord-blood-registry-cbr-by-generate-life-sciences-partners-with-nantkwest-to-develop-covid-19-treatment/
Lirumlarum1,
22.08.2020 15:50 Uhr
0
ImmunityBio Study Shows Positive T Cell and Antibody Immune Responses to its COVID-19 Vaccine Candidate that Targets Both Spike and Nucleocapsid Virus Proteins
https://nantkwest.com/immunitybio-study-shows-positive-t-cell-and-antibody-immune-responses-to-its-covid-19-vaccine-candidate-that-targets-both-spike-and-nucleocapsid-virus-proteins/
Lirumlarum1,
22.08.2020 15:48 Uhr
0
Harry Reid about NantKwest:
'It Must be Witchcraft’ as Harry M Reid’s Life Saved by Combination Therapy Delivered by the ‘Unconventional’ Dr. Patrick Soon-Shiong
JUN 13, 2020 | CANCER, IMMUNOTHERAPY, ONCOLOGY, PANCREATIC CANCER
https://www.trialsitenews.com/it-must-be-witchcraft-as-harry-m-reids-life-saved-by-combination-therapy-delivered-by-the-unconventional-dr-patrick-soon-shiong/
Lirumlarum1,
22.08.2020 15:46 Uhr
0
NantKwest Announces Studies in collaboration with the National Cancer Institute Demonstrating Enhanced Killing Activity of First-in-Class PD-L1 t-haNK Natural Killer Cell Across Every Cancer Cell Line Tested
Jun 10, 2020 | Press Releases
NantKwest’s antibody-targeted NK cell line, haNK, which is engineered for increased antibody-dependent cell-mediated cytotoxicity and activation, showed increased resistance to hypoxic conditions as seen in suppressive tumor microenvironments
NantKwest’s PD-L1 t-haNK cells, haNK cells engineered to express PD-L1 checkpoint-directed chimeric antigen receptors, demonstrated in-vivo tumor trafficking, significant elimination of both monocytic and granulocytic MDSCs and demonstrated robust anti-tumor activity in cancer cell lines and in mouse models
Studies demonstrated the ability of PD-L1 t-haNK to kill 20 out of 20 human cancer cell lines tested, including triple negative breast cancer (TNBC) and lung, urogenital, and gastric cancer cells
https://nantkwest.com/nantkwest-announces-studies-in-collaboration-with-the-national-cancer-institute-demonstrating-enhanced-killing-activity-of-first-in-class-pd-l1-t-hank-natural-killer-cell-across-every-cancer-cell-line/
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | NANTKWEST INC. DL-,0001 Hauptdiskussion | ||
| 2 | News, Infos & good to know |
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | Micron Neu | -7,10 % | |
| 2 | VONOVIA Hauptdiskussion | -1,23 % | |
| 3 | MODERNA INC. DL-,0001 Hauptdiskussion | -8,38 % | |
| 4 | NVIDIA Hauptdiskussion | -2,57 % | |
| 5 | PLUG POWER Hauptdiskussion | -3,82 % | |
| 6 | IDORSIA AG SF-,05 Hauptdiskussion | -3,73 % | |
| 7 | für alle, die es ehrlich meinen beim Traden. | ||
| 8 | Beyond Meat Hauptforum | -4,23 % | |
| 9 | FuelCell Energy Inc Registered Shs Hauptdiskussion | -8,89 % | |
| 10 | Metaplanet | -1,55 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | VONOVIA Hauptdiskussion | -1,23 % | |
| 2 | Micron Neu | -7,02 % | |
| 3 | MODERNA INC. DL-,0001 Hauptdiskussion | -8,38 % | |
| 4 | PLUG POWER Hauptdiskussion | -3,82 % | |
| 5 | NVIDIA Hauptdiskussion | -2,73 % | |
| 6 | IDORSIA AG SF-,05 Hauptdiskussion | -3,73 % | |
| 7 | Beyond Meat Hauptforum | -4,23 % | |
| 8 | BLOOM ENERGY A Hauptdiskussion | -3,60 % | |
| 9 | FuelCell Energy Inc Registered Shs Hauptdiskussion | -8,89 % | |
| 10 | Metaplanet | -1,28 % | Alle Diskussionen |